title: [Necrotizing myopathy associated with anti-SRP auto-antibodies: transient efficacy of a therapeutic strategy associating plasma exchanges and rituximab].
authors.forename: Léa
authors.initials: L
authors.lastname: Savey
authors.forename: Guillaume
authors.initials: G
authors.lastname: Bussone
authors.forename: Annie
authors.initials: A
authors.lastname: Lannuzel
authors.forename: Claire
authors.initials: C
authors.lastname: Goulvestre
authors.forename: Loïc
authors.initials: L
authors.lastname: Guillevin
authors.forename: Luc
authors.initials: L
authors.lastname: Mouthon
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D001323:Autoantibodies / Q000009:adverse effects*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D008875:Middle Aged; D018482:Muscle, Skeletal / Q000276:immunology / Q000473:pathology; D009135:Muscular Diseases / Q000209:etiology / Q000276:immunology / Q000628:therapy*; D009336:Necrosis / Q000209:etiology; D010951:Plasma Exchange / Q000379:methods; D000069283:Rituximab; D018271:Signal Recognition Particle / Q000276:immunology*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies; D007155:Immunologic Factors; D018271:Signal Recognition Particle; D000069283:Rituximab